Janus Henderson Investors US’s Insmed INSM Stock Holding History

Janus Henderson Investors US’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$49.2M	Sell	2,809,457 -46,119	-2%	-$711K	0.04%	447
2016 Q4	$37.8M	Sell	2,855,576 -21,961	-0.8%	-$300K	0.03%	492
2016 Q3	$41.8M	Buy	2,877,537 +23,599	+0.8%	+$295K	0.04%	457
2016 Q2	$28.1M	Sell	2,853,938 -59,979	-2%	-$700K	0.02%	518
2016 Q1	$36.9M	Sell	2,913,917 -57,322	-2%	-$754K	0.03%	474
2015 Q4	$53.9M	Buy	2,971,239 +383,844	+15%	+$6.76M	0.05%	397
2015 Q3	$48M	Buy	2,587,395 +350,364	+16%	+$8.75M	0.04%	425
2015 Q2	$54.6M	Buy	2,237,031 +269,903	+14%	+$6.13M	0.04%	432
2015 Q1	$40.9M	Buy	1,967,128 +590,241	+43%	+$10.4M	0.03%	498
2014 Q4	$21.3M	Buy	1,376,887 +178,527	+15%	+$2.53M	0.02%	590
2014 Q3	$15.6M	Buy	+1,198,360	New	+$18.1M	0.01%	621

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Janus Henderson Investors US's INSM Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Insmed (INSM) stake by 1.6% in Q1 2017, selling an estimated $711K and leaving 2,809,457 shares worth $49.2M. The position accounts for 0.04% of the portfolio, ranked #447.

Janus Henderson Investors US first reported a position in INSM in Q3 2014 and has held it in 11 quarters since. The position peaked at $54.6M in Q2 2015. 100 funds tracked by Wall St. Rank hold INSM as of Q1 2017.

Janus Henderson Investors US held 2,809,457 shares of Insmed worth $49.2M as of Q1 2017.
Janus Henderson Investors US sold 46,119 Insmed shares in Q1 2017, an estimated $711K.
Insmed made up 0.04% of Janus Henderson Investors US's portfolio in Q1 2017, its #447 holding.
Janus Henderson Investors US first reported a position in Insmed in Q3 2014 and has held it in 11 quarters since.
Janus Henderson Investors US's Insmed position peaked at $54.6M in Q2 2015.
100 funds tracked by Wall St. Rank held Insmed as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.